Blood Processing Devices and Consumables Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Devices, Consumables), By Usage (Red Blood Cells, Plasma, Platelets, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 46.57 Billion
CAGR (2026-2031)	5.53%
Fastest Growing Segment	Devices
Largest Market	North America
Market Size (2031)	USD 64.32 Billion

Market Overview

The Global Blood Processing Devices and Consumables Market is projected to grow from USD 46.57 Billion in 2025 to USD 64.32 Billion by 2031 at a 5.53% CAGR. The global blood processing devices and consumables market encompasses instrumentation and disposable products essential for the collection, separation, filtration, and storage of whole blood and its constituent components. Key drivers supporting market expansion include the increasing incidence of chronic diseases necessitating blood transfusions, a growing volume of surgical interventions, and elevated awareness concerning blood safety protocols. According to the AABB National Blood Collection and Utilization Survey, in 2023, 11.58 million red blood cell units were collected in the United States, underscoring the substantial volume processed annually.

A significant challenge impeding market growth is the stringent and evolving global regulatory environment governing blood products and medical devices. This regulatory complexity necessitates considerable investment in compliance, potentially delaying product launches and increasing operational expenditures across the industry.

Key Market Drivers

The rising prevalence of chronic and infectious diseases significantly influences the global blood processing devices and consumables market by increasing the demand for blood and its components for diagnostic and therapeutic purposes. Conditions such as various cancers, autoimmune disorders, and severe infections often necessitate blood transfusions or therapies derived from blood plasma. For instance, according to the World Health Organization, noncommunicable diseases were collectively responsible for 74% of all deaths worldwide, highlighting the extensive patient population potentially requiring blood-related interventions. This sustained and growing need for blood components drives the consistent demand for advanced blood processing devices that can efficiently and safely prepare diverse blood products for transfusion and other medical applications.

Technological advancements in blood processing and storage represent another critical driver, pushing innovation in devices and consumables to enhance efficiency, safety, and component quality. These advancements include automated systems for blood component separation, improved filtration techniques, and sophisticated storage solutions that extend shelf life and maintain product integrity. For example, according to Terumo Blood and Cell Technologies, in October 2024, their Reveos™ Automated Blood Processing System, launched in the U.S., reduces manual steps by up to 65% in whole blood separation, illustrating the impact of automation on operational efficiency. Such innovations are essential for meeting the complex demands of modern healthcare, with the global value of plasma and its derivatives alone estimated at $35.8 billion in 2024, according to The Global Plasma Economy.

Download Free Sample Report

Key Market Challenges

The stringent and evolving global regulatory environment presents a substantial impediment to the growth of the global blood processing devices and consumables market. Adherence to diverse and frequently updated regulations across various international jurisdictions demands considerable investment in terms of both financial capital and operational expertise. This inherent complexity in navigating approval pathways creates barriers for market entry, particularly for smaller innovators, and also prolongs product development and commercialization cycles.

Such regulatory intricacy directly hampers market expansion by delaying the introduction of advanced technologies and essential solutions for blood collection, separation, filtration, and storage. For instance, according to the MedTech Europe IVDR & MDR Survey Results, in 2024, the average time for medical device manufacturers to complete Technical Documentation Assessment (TDA) for CE-marking in Europe was 21.8 months. These extended timelines translate into increased research and development costs, deferred revenue generation, and ultimately, a slower pace of innovation and product availability within this critical market segment.

Key Market Trends

Decentralization and mobility in blood collection and processing is profoundly impacting the global blood processing devices and consumables market by shifting collection points away from traditional hospital or clinic settings. This trend is driven by demand for greater accessibility, convenience, and faster response times, particularly for emergency and remote healthcare needs. Innovations facilitating this shift include mobile blood donation units and prehospital transfusion programs that deliver blood products directly to patients. For instance, according to America's Blood Centers, in May 2025, their report revealed the number of community blood centers providing blood products for prehospital use nearly doubled from 18 centers in 2022 to 34 centers in 2024. This expansion necessitates specialized, portable processing and storage solutions adaptable to diverse environments.

The development of patient-centric and minimally invasive blood collection devices is another significant trend reshaping the market, focusing on enhancing the donor and patient experience. These innovations aim to reduce pain, anxiety, and complications associated with traditional venipuncture. Technologies such as micro-sampling devices, capillary blood collection systems, and needle-free solutions are gaining traction, especially for sensitive populations or those requiring frequent blood draws. These devices often require smaller blood volumes while maintaining diagnostic accuracy. According to Ash, in May 2025, in their announcement "From Finger Prick to One Click: Ash Launches Tasso Blood Collection Device", over 95% of users preferred the Tasso device over legacy blood collection methods. This trend influences the design and adoption of new blood collection and initial processing consumables.

Segmental Insights

The Devices segment is experiencing rapid growth within the Global Blood Processing Devices and Consumables Market, becoming the fastest-growing product category. This expansion is primarily driven by continuous technological advancements that enhance device performance, safety, and user-friendliness in blood handling and component separation. The increasing demand for automation, precision, and efficiency in blood processing workflows also fuels this growth, as healthcare systems worldwide prioritize robust solutions for patient care. Furthermore, stringent regulatory standards set by bodies such as the U.S. Food and Drug Administration (FDA), particularly its Center for Biologics Evaluation and Research (CBER), necessitate reliable and advanced devices to ensure blood safety and quality.

Regional Insights

North America leads the global blood processing devices and consumables market, driven by its sophisticated healthcare infrastructure and significant investments in medical technology. The region benefits from early and extensive adoption of innovative blood processing technologies, alongside a robust network of hospitals, blood banks, and diagnostic laboratories. This dominance is further underpinned by a strong regulatory framework, notably enforced by the U.S. Food and Drug Administration (FDA), which sets stringent standards for blood collection, processing, and product manufacturing. Additionally, adherence to guidelines from organizations such as the AABB (Association for the Advancement of Blood & Biotherapies) ensures high quality and safety in blood-related practices across the region.

Recent Developments

• In April 2026, Vitestro published the results of its multicenter clinical study in Clinical Chemistry, which validated its Aletta® Autonomous Robotic Phlebotomy Device™ (ARPD™). The study demonstrated strong performance, safety, and patient experience for diagnostic blood collection using the device. This fully autonomous robotic system utilizes multimodal imaging, including near-infrared vein visualization and real-time ultrasound, to perform venous blood draws. The research indicated a high first-stick success rate and a low hemolysis rate, supporting the device’s potential for broader adoption in routine clinical practice within the global blood processing devices market.
• In January 2026, Truvian Health received U.S. Food and Drug Administration (FDA) clearance for the Complete Blood Count (CBC) on its TruVerus multi-modal blood testing system. This clearance marked a significant platform advancement, expanding the TruVerus system to 26 cleared assays. It represented the first FDA clearance for Complete Blood Count from a lithium heparin sample. The TruVerus system is a tabletop device designed to deliver comprehensive routine blood testing from a single sample, aiming to reduce the need for multiple tubes and instruments, thereby streamlining workflows in decentralized care settings and impacting the global blood processing devices market.
• In November 2025, Velico announced a significant expansion of its manufacturing and supply chain operations. This expansion aimed to meet the growing demand for its FrontlineODP™ Spray Dried Plasma Manufacturing System. Velico's Plasma Drying Chamber is a crucial consumable for producing FrontlineODP™ Spray Dried Plasma, a system designed to enable military and civilian blood centers to rapidly produce dried plasma from liquid donor plasma. The company finalized plans for new production facilities dedicated to manufacturing these consumables for the European and Indo-Pacific markets, with expected combined production to exceed 100,000 units annually. This initiative directly supports the global blood processing devices and consumables market.
• In July 2025, OraSure Technologies, through its subsidiary DNA Genotek, launched the HEMAcollect™●PROTEIN product. This evacuated blood collection tube was designed to preserve and stabilize plasma proteins within whole blood for up to seven days, representing a significant advancement in sample management solutions for proteomic research. The product aims to enhance the quality of insights for researchers and is compatible with various proteomic technologies, including mass spectrometry and immunoassays. It minimizes hemolysis and platelet activation, ensuring sample integrity. This new consumable directly addresses evolving needs in the global blood processing devices and consumables market by improving preanalytical workflows.

Key Market Players

• Beckman Coulter, Inc.
• Haemonetics Corporation
• Maco Pharma International GmbH
• Poly Medicure Ltd.
• Immucor, Inc.
• Fresenius SE & Co KGaA
• Neomedic Limited
• Global Scientific Company
• Sigma Laborzentrifugen GmbH
• Terumo BCT, Inc.

By Product	By Usage	By Region
Devices Consumables	Red Blood Cells Plasma Platelets Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Blood Processing Devices and Consumables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Processing Devices and Consumables Market, By Product:

• Devices
• Consumables

• Blood Processing Devices and Consumables Market, By Usage:

• Red Blood Cells
• Plasma
• Platelets
• Others

• Blood Processing Devices and Consumables Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE